Effect of the Lumbar Sympathetic Block on Pain in Patients with Symptomatic Peripheral Arterial Disease-Retrospective Analysis Semptomatik Periferik Arter Hastalarında Lomber Sempatik Bloğun Ağrı Üzerine Etkisi-Retrospektif Analiz

Creative Commons License

Kaya S. S., Celik S., AKÇABOY E. Y., Goksu H., Ayhan M. Y., ŞAHİN Ş.

Anestezi Dergisi, cilt.30, sa.3, ss.188-192, 2022 (Scopus, TRDizin)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 30 Sayı: 3
  • Basım Tarihi: 2022
  • Doi Numarası: 10.54875/jarss.2022.58076
  • Dergi Adı: Anestezi Dergisi
  • Derginin Tarandığı İndeksler: Scopus, Academic Search Premier, Central & Eastern European Academic Source (CEEAS), EMBASE, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.188-192
  • Anahtar Kelimeler: claudication, pain, peripheral arterial disease, Sympathetic nerve block, visual analog scale
  • Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
  • Sağlık Bilimleri Üniversitesi Adresli: Evet

Özet

Objective: To study the effect of lumbar sympathetic block (LSB) with a mixture of local anesthetics and steroids on pain in patients with chronic ischemic lower limb disease. Methods: Retrospectively 23 patients were reviewed with peripheral arterial disease who underwent LSB using a mixture of 8 mg of dexamethasone, 80 mg of 2% lidocaine, and 4 mL of saline at 2 levels, L2 and L4, under the guidance of fluoroscopy. Recordings of the Visual Analog Scale (VAS) scores at 3 days before the blockage, and 1 month and 3 months after treatment were obtained. Results: The study included 20 (87%) male and 3 (13%) female patients. The mean age of the patients was 59.65±13.33 years. The patients’ post-blockage 3rd day, and 1st and 3rd month VAS scores were significantly lower than the baseline VAS scores (p<0.05). The proportion of patients with 50% improvement in the VAS scores at 3rd days, and 1st and 3rd months was 47.8%, 21.7%, and 21.7%, respectively. No complications or side effects were observed. Conclusion: Lumbar sympathetic block with a mixture of local anesthetics and steroids appears to be effective in patients who have non-reconstructable arterial occlusive disease, with reduced pain scores and low complication rates.